Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma.
Quinn JA, Pluda J, Dolan ME, Delaney S, Kaplan R, Rich JN, Friedman AH, Reardon DA, Sampson JH, Colvin OM, Haglund MM, Pegg AE, Moschel RC, McLendon RE, Provenzale JM, Gururangan S, Tourt-Uhlig S, Herndon JE 2nd, Bigner DD, Friedman HS.
Quinn JA, et al. Among authors: bigner dd.
J Clin Oncol. 2002 May 1;20(9):2277-83. doi: 10.1200/JCO.2002.09.084.
J Clin Oncol. 2002.
PMID: 11980998
Clinical Trial.